Biography:
GUO Zhengjun, holds a Ph.D. from Army Medical University, completed postdoctoral training at City University of Hong Kong, and serves as an Attending Physician at the Cancer Center of the Second Affiliated Hospital of Chongqing Medical University. Specializing in the malignant biological behavior and mechanisms of cancer stem cells in lung and gastric cancers, they have extensive experience in multimodal cancer therapies including immunotherapy, targeted therapy, and radiotherapy. Their research focuses on developing clinical prediction models through radiomics and multimodal AI technology, and they are skilled in designing multi-route nanomedicine delivery systems for antitumor treatment.